Dallas, TX -- (SBWire) -- 07/07/2014 --ReportsnReports.com adds “PharmaPoint: Prophylactic Human PapillomaVirus Vaccines Current and Future Players” report to its research database.
"PharmaPoint: Prophylactic Human PapillomaVirus Vaccines Current and Future Players". The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Prophylactic Human Papillomavirus Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Prophylactic Human Papillomavirus Vaccines market. The report provides insight into the competitive Prophylactic Human Papillomavirus Vaccines landscape, including new companies entering the market.
Companies Mentioned in report:
- Merck
- GSK
Order a Purchase copy @ http://www.reportsnreports.com/Purchase.aspx?name=291516 .
Scope
- Investigation of current and future market competition for Prophylactic Human Papillomavirus Vaccines
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Prophylactic Human Papillomavirus Vaccines sector through market impact analysis, future market scenario and company analysis
Reasons to buy
- Gain a high level view of the trends shaping and driving Prophylactic Human Papillomavirus Vaccines market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What's the next big thing in the global Prophylactic Human Papillomavirus Vaccines market landscape? Identify, understand and capitalize
Complete Report Details @ http://www.reportsnreports.com/reports/291516-pharmapoint-prophylactic-human-papillomavirus-vaccines-current-and-future-players.html .
Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Related Reports 8
2.3 Upcoming Related Reports 9
3 Market Outlook 10
3.1 Global Markets 10
3.1.1 Forecast 10
3.1.2 Drivers and Barriers - Global Issues 12
4 Current and Future Players 17
4.1 Overview 17
4.2 Trends in Corporate Strategy 19
4.3 Company Profiles 20
4.3.1 Merck 20
4.3.2 GSK 23
5 Appendix 26
5.1 Bibliography 26
5.2 Abbreviations 30
5.3 Methodology 31
5.4 Forecasting Methodology 31
5.4.1 Vaccine Coverage 32
5.4.2 Vaccine Approval versus Routine Schedule Inclusion 32
5.4.3 General Pricing Assumptions 33
5.5 Physicians and Specialists Included in this Study 34
5.6 About the Author(s) 37
5.6.1 Author(s) 37
5.6.2 Therapy Area Director 37
5.6.3 Global Head of Healthcare 38
5.7 About GlobalData 39
5.8 Disclaimer 39
List of Tables
Table 1: Global Sales Forecasts ($m) for HPV Vaccines, 2012-2022 10
Table 2: Global HPV Vaccine Market - Drivers and Barriers, 2014 12
Table 3: Key Companies in the HPV Vaccine Market, 2014 18
Table 4: Merck's HPV Vaccine Portfolio Assessment, 2014 22
Table 5: Merck SWOT Analysis, 2014 22
Table 6: GSK's HPV Vaccine Portfolio Assessment, 2014 24
Table 7: GSK SWOT Analysis, 2014 25
Table 8: High-Prescribing Physicians (non-KOLs) Surveyed, By Country 36
List of Figures
Figure 1: Global Sales for HPV Vaccines by Region, 2012-2022 11
Figure 2: Company Portfolio Gap Analysis in HPV Vaccines, 2012-2022 18
Browse more reports on Pharmaceuticals Market @ http://www.reportsnreports.com/market-research/pharmaceuticals/ .
Connect US:
Twitter: https://twitter.com/RnRMR
Facebook: http://www.facebook.com/pages/RnR-Market-Research/413488545356345
Google Plus: https://plus.google.com/u/0/104156468549256253075/posts
Prophylactic Human Papillomavirus Vaccines Market Analysis on Current and Future Players